MedTrace Logo

Comparison of Moxifloxacin With Ciprofloxacin/Metronidazole on Patients With Chronic Periodontitis

NCT00805558 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2010-05-12

No results posted yet for this study

Summary

The purpose of this study is to assess the clinical and microbiological effectiveness of the moxifloxacin compared with the combination ciprofloxacin - metronidazole, when used as adjunctive therapy to scaling and root planning for the treatment of advanced chronic periodontitis.

Conditions

  • Chronic Periodontitis

Interventions

DRUG

moxifloxacin

400 mg moxifloxacin once daily for 7 days

DRUG

Ciprofloxacin plus metronidazole

Ciprofloxacin 1000 mg once daily for 7 days; Metronidazole 500 mg twice daily for 7 days

Sponsors & Collaborators

  • Universidad de Antioquia

    collaborator OTHER

  • Facultad Nacional de Salud Publica

    lead OTHER

Principal Investigators

  • Carlos M Ardila, DDS Cand PhD · Grupo Epidemiologia Universidad de Antioquia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2009-12-31
Completion
2010-04-30

Countries

  • Colombia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00805558 on ClinicalTrials.gov